Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
about
Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma.Quantitative mass spectrometry analysis of PD-L1 protein expression, N-glycosylation and expression stoichiometry with PD-1 and PD-L2 in human melanoma.Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells.Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade.Mechanisms of Resistance to Immune Checkpoint Antibodies.Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.Genomic Analysis of Tumor Microenvironment Immune Types across 14 Solid Cancer Types: Immunotherapeutic Implications.Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients.Melanoma subtypes demonstrate distinct PD-L1 expression profiles.Therapeutic Cancer Vaccines: How Much Closer Are We?Trial watch: Immune checkpoint blockers for cancer therapy.Implications of the tumor immune microenvironment for staging and therapeutics.Role of immune-checkpoint inhibitors in lung cancer.Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.GDNF secreted by nerves enhances PD-L1 expression via JAK2-STAT1 signaling activation in HNSCC.The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.Second-Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review.Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in IRegulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion.Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).Immuno-Oncology: Emerging Targets and Combination TherapiesPrognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
P2860
Q33814322-2CDBB7A0-C5F0-49E7-AB1B-32EE0BE58808Q36382143-15C46EC0-A757-426A-B7AF-B4B25CFD0155Q37525422-BD31D881-24F4-41CF-93DA-F486972A66D1Q37713680-443FA8B0-8CDA-44EF-B4D9-58B3DBCA4303Q39185608-2A097D4A-E64A-42BE-94D6-66C38E28099EQ39243060-C04650C3-E59D-47E9-AE47-C42D16C4B45DQ41173680-A9573B88-F82F-4853-BABE-589FBE3F2A04Q46721978-4A786FFB-46EE-4FA2-8520-F58FA6D6322EQ47098333-5E2E7E79-29F7-4A32-85AB-9BF28ECFD9E0Q47106167-3D842935-D3F6-415D-A85C-2F6CA0456629Q47107364-D593FCC9-2BE7-417F-B802-E79AAAB3B450Q47235984-9641BB1E-B482-45A0-9209-2F2F0AE6436CQ47393365-47C8E859-8A0C-4B4B-BA7B-29B10377CCB9Q47592007-7A374EB8-E20B-4C7B-BFEE-49912699D29CQ49549096-EAD593AC-FAC7-4AA9-B778-6DC5A2436FE7Q50077322-30BEE84E-6E94-4B16-BBA3-03C72750E20BQ50440650-1338551E-1867-40C4-AF10-CFA180CD2F7DQ50545414-89C48DF0-E92D-492F-ABFE-4CB5BFDEAE5EQ50983217-B2CC51A2-58D7-4587-AA9F-BEABE4FE02F6Q52682465-A4FB83D4-952C-4E4B-BEDA-7354408AE879Q53075272-7213D74F-4697-49F8-8D80-14069ACB6563Q54685474-BCC3F951-257D-4114-BCAE-56F969CA87A8Q55100565-23BE9DC9-67B6-40D2-9CC1-C857D6B29788Q55709201-4C18E99A-4B78-42A6-9761-7FDC7889B52AQ56889817-EE63C29D-9D7C-4739-BAC0-B2381008A53AQ57191808-B2BFD70E-98D9-4B33-A83A-EB6AE3FB4CDF
P2860
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Association of PD-1/PD-L axis ...... lanoma and other solid tumors.
@en
Association of PD-1/PD-L axis ...... lanoma and other solid tumors.
@nl
type
label
Association of PD-1/PD-L axis ...... lanoma and other solid tumors.
@en
Association of PD-1/PD-L axis ...... lanoma and other solid tumors.
@nl
prefLabel
Association of PD-1/PD-L axis ...... lanoma and other solid tumors.
@en
Association of PD-1/PD-L axis ...... lanoma and other solid tumors.
@nl
P2093
P2860
P356
P1476
Association of PD-1/PD-L axis ...... lanoma and other solid tumors.
@en
P2093
Charles G Drake
Drew M Pardoll
Genevieve J Kaunitz
Haiying Xu
Janis M Taube
Jessica Esandrio
Leslie Cope
Robert A Anders
Tricia R Cottrell
P2860
P304
E7769-E7777
P356
10.1073/PNAS.1607836113
P407
P577
2016-11-11T00:00:00Z